Education & Resources

ACCC eXchange LogIn Corporate Member Sponsored Resources Presentations & Abstracts President's Theme ACCC Connect eLearning LogIn

Oncology Issues Patient Assistance & Reimbursement Guide Trending Now in Cancer Care

2026 ACCC Leadership Summit Annual Meeting & Cancer Center Business Summit Capitol Hill Day National Oncology Conference Oncology Reimbursement Meetings Oncology State Society Meetings

Policy & Advocacy

2024 Policy Wrap-Up and ACCC 2025 Policy Priorities Letters & Statements Access, Payment & Reimbursement Reform White Bagging & Brown Bagging Advocacy Resources Cancer Moonshot

Join | Renew Who We Are Membership Types & Benefits Corporate Members ACCC Member Portal FAQ Member Directory

Partners

Oncology State Societies Partner Organizations CME

News Releases Advocacy News Releases Oncology News

Timeline / 50th Anniversary 2025 Impact Report ACCC Innovator Awards ACCC Fellows ACCC Senior Staff

Breast Cancer Metastatic Breast Cancer

Gastrointestinal Cancer Biliary Tract Cancer Colorectal Cancer Gastric Cancer Liver Cancer

Genitourinary Cancer Bladder Cancer Prostate Cancer Renal Cell Carcinoma

Gynecologic Cancer Ovarian Cancer

Head & Neck Cancer

Hematologic Malignancies Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)

Lung Cancer Non-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)

Skin Cancer Melanoma Non-Melanoma Skin Cancers (NMSC)

Clinical Practice & Treatment Cancer Diagnostics Care Coordination EHR Integration for Biomarker Testing Quality Improvement Collaboration: Integration of Precision Medicine in Community Oncology Treatment

Financial Navigation FAN Boot Camp Financial Advocacy Network (FAN) Resource Library Patient Assistance & Reimbursement Guide Prior Authorization

Health Equity & Access 3, 2, 1, Go! Practical Solutions for Addressing Cancer Care Disparities Appalachian Community Cancer Alliance Oncology Advanced Practitioners Personalizing Care for Patients of All Backgrounds Social Drivers of Health

Patient-Centered Care Addressing Care Disparities for Veterans Adolescent and Young Adult (AYA)Care Action Plans for People with Cancer Dermatologic Toxicities Empowering Caregivers Geriatric Oncology Health Literacy Nutrition Oncology Pharmacy Patient Navigation Psychosocial Care in Oncology Shared Decision-Making Supportive Care Survivorship Care

Practice Management & Operations Cancer Program Fundamentals Leadership Sustainment and Engagement Videos Oncology Practice Transformation and Integration Center Oncology Team Resiliency

Research ACCC Community Oncology Research Institute (ACORI)

Technology & InnovationTelehealth & Digital Medicine

CANCER BUZZ Podcast

Oncology Issues

Breast Cancer Metastatic Breast Cancer

Gastrointestinal Cancer Biliary Tract Cancer Colorectal Cancer Gastric Cancer Liver Cancer

Genitourinary Cancer Bladder Cancer Prostate Cancer Renal Cell Carcinoma

Gynecologic Cancer Ovarian Cancer

Head & Neck Cancer

Hematologic Malignancies Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)

Lung Cancer Non-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)

Skin Cancer Melanoma Non-Melanoma Skin Cancers (NMSC)

Clinical Practice & Treatment Cancer Diagnostics Care Coordination EHR Integration for Biomarker Testing Quality Improvement Collaboration: Integration of Precision Medicine in Community Oncology Treatment

Financial Navigation FAN Boot Camp Financial Advocacy Network (FAN) Resource Library Patient Assistance & Reimbursement Guide Prior Authorization

Health Equity & Access 3, 2, 1, Go! Practical Solutions for Addressing Cancer Care Disparities Appalachian Community Cancer Alliance Oncology Advanced Practitioners Personalizing Care for Patients of All Backgrounds Social Drivers of Health

Patient-Centered Care Addressing Care Disparities for Veterans Adolescent and Young Adult (AYA)Care Action Plans for People with Cancer Dermatologic Toxicities Empowering Caregivers Geriatric Oncology Health Literacy Nutrition Oncology Pharmacy Patient Navigation Psychosocial Care in Oncology Shared Decision-Making Supportive Care Survivorship Care

Practice Management & Operations Cancer Program Fundamentals Leadership Sustainment and Engagement Videos Oncology Practice Transformation and Integration Center Oncology Team Resiliency

Research ACCC Community Oncology Research Institute (ACORI)

Technology & InnovationTelehealth & Digital Medicine

CANCER BUZZ Podcast

Oncology Issues

1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us

Contact Us Volunteers

Terms and Conditions

ACCC Rebranding

Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.

Advertisement

News

Article

June 2, 2020

FDA Approves Atezolizumab + Bevacizumab for Previously Untreated Advanced HCC

On May 29, 2020, the U.S. Food and Drug Administration (FDA) approved atezolizumab in combination with bevacizumab (Tecentriq and Avastin, Genentech Inc.) for patients with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.

Read full FDA announcement.

Tecentriq prescribing information and billing/coding for HCC.

Avastin prescribing information and billing/coding for HCC.

Posted 6/2/2020